Publication | Closed Access
Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma
19
Citations
24
References
2016
Year
Collectively, these data demonstrate that therapeutic inhibition of the MDM2-p53 interaction with MI-773 activates downstream effectors of apoptosis and causes robust tumor regression in preclinical models of ACC. Clin Cancer Res; 22(14); 3550-9. ©2016 AACR.
| Year | Citations | |
|---|---|---|
Page 1
Page 1